Karen Ferrante

Karen Jean Ferrante is an Independent Director at Cogent Biosciences, Inc. and MacroGenics, Inc. She is also a Director at New England Women In Science Executives Club.
Previously, she held positions as an Associate Director at Bristol Myers Squibb Co., an Independent Director at Progenics Pharmaceuticals, Inc., an Independent Non-Executive Director at HUTCHMED (China) Ltd., an Independent Director at Baxalta, Inc., and Vice President-Oncology Development at Pfizer Inc. She also served as the Head-Oncology Therapeutic Area at Millennium Pharmaceuticals, Inc. and as the Chief Medical Officer at Takeda Pharmaceutical Co., Ltd.
She was the Chief Medical Officer and Head-Research & Technology at Tokai Pharmaceuticals, Inc. Additionally, she held the position of Vice President-Oncology Department at Pfizer (St. Louis).
Dr. Ferrante received her undergraduate degree from Providence College and her doctorate degree from Georgetown University.